Danny Lascano

Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy

Meera R. Chappidi, Max Kates, Hiten D. Patel et al. · Urologic Oncology Seminars and Original Investigations · 2016 · 124 citations · Full text

Radical Cystectomy, Urology, Surgical Oncology +7

Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools

Danny Lascano, Jamie S. Pak, Max Kates et al. · Urologic Oncology Seminars and Original Investigations · 2015 · 106 citations · Full text

Urologic Malignancy, Urology, Surgical Oncology +11

Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors

Reem Berro, Per Johan Klasse, Danny Lascano et al. · Journal of Virology · 2011 · 64 citations · Full text

Immunology, Molecular Biology, Antigen Processing +18

Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants

Reem Berro, Anila Yasmeen, Ravinder Abrol et al. · Journal of Virology · 2013 · 40 citations · Full text

Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery

Rodrigo Ledezma, Edris Negron, Gladell P. Paner et al. · World Journal of Urology · 2015 · 34 citations

Type 1, Urology, Surgical Oncology +8